Ultragenyx Pharmaceutical (RARE) Treasury Shares (2014 - 2026)

Ultragenyx Pharmaceutical (RARE) has 4 years of Treasury Shares data on file, last reported at $10.0 million in Q1 2026.

• Quarterly Treasury Shares rose 32.17% year-over-year to $10.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.0 million (up 32.17% YoY) and the FY2025 annual result came in at $8.0 million, up 100.0% from the prior year.
• Treasury Shares rose to $10.0 million in Q1 2026 per RARE's latest filing, from $8.0 million in the prior quarter.
• Across five years, Treasury Shares topped out at $1.2 million in Q4 2024 and bottomed at $7812.0 in Q1 2023.
• The 4-year median for Treasury Shares is $68923.0 (2024), against an average of $187710.2.
• The widest annual swing landed in 2024, when Treasury Shares jumped 835.96%; it then surged 32.17% in 2026.
• Tracing RARE's Treasury Shares over 4 years: stood at $432000.0 in 2023, then soared by 825.93% to $4.0 million in 2024, then surged by 100.0% to $8.0 million in 2025, then rose by 25.0% to $10.0 million in 2026.
• Per Business Quant, the three latest RARE Treasury Shares figures stand at $10.0 million (Q1 2026), $8.0 million (Q4 2025), and $8.0 million (Q3 2025).

Peer Comparison